Both plasma and tumor tissue were tested using the Cobas assay with a sensitivity of 76.7% (range 70.5–81.9%) for the detection of EGFR-sensitizing mutations and a specificity of 98.2% (range 95.4–99.3%) when using tissue genotypes as reference standards [16]. The gene discussed is EGFR; the disease is neoplasm.